The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effects when given alone

Pharmacology and Toxicology

Volumn 84, Issue 5, 1999, Pages 226-233

  Johansson, Christina ^a   Deveney, Aaron M ^a   Reif, David ^b   Jackson, David M ^a,c,d  

^a Research and Development at Scania Technical Centre   (Sweden)

^b Astra Arcus USA   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDINE; AR R 17477; DEXAMPHETAMINE; N [4 [2 [(3 CHLOROPHENYLMETHYL)AMINO]ETHYL]PHENYL] 2 THIOPHENECARBOXAMIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENCYCLIDINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACOUSTIC REFLEX; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SELECTIVITY; HEART RATE; LOCOMOTION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; RAT; STARTLE REFLEX; SUBCUTANEOUS DRUG ADMINISTRATION; TELEMETRY;

ANIMALIA;

EID: 0032932241     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1999.tb01487.x     Document Type: Article

References (29)

1. Akbarian , S., A. Vinuela, J. J. Kim, S. G. Potkin, W. E. Bunney & E. G. Jones: Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry 1993, 50, 178-187.
2. Arima, T., T. Mizuno, Y. Ohshima, Y. Kitamura, T. Segawa & Y. Nomura: 5-Hydroxytryptamine-induced Ca2+-independent cGMP formation is mediated by nitric oxide in a nitric oxide synthase-independent manner in NG108-15 cells. Neurosci. Res. 1997, 27, 229-233.
3. Bakshi, V. P. & M. A. Geyer: Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacol. 1995, 122, 198-201.
4. Bredt, D. S. & S. H. Snyder: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proceedings of the National Academy of Sciences of the United States of America. 1990, 87, 682-685.
5. Das, I., N. S. Khan, B. K. Puri, S. R. Sooranna, J. de Belleroche & S. R. Hirsch: Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem. Biophys. Res. Comm. 1995, 212, 375-380.
6. Fray, P. J., B. J. Sahakian, T. W. Robbins, G. F. Koob & S. D. Iversen: An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine. Psychopharmacol. 1980, 69, 253-259.
7. Gentile, R. J., R. J. Murray, J. E. MacDonald & W. C. Shakespeare: Amidine derivatives with nitric oxide synthase activities. International Patent Application Number WO 95/05363 (February 23, 1995).
8. Gleason, S. D. & H. D. Shannon: Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacol. 1997, 129, 79-84.
9. Inoue, H., I. Arai, S. Shibata & S. Watanabe: NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitisation and enhancement of striatal dopamine release. J. Pharmacol. Exp. Therap. 1996, 277, 1424-1430.
10. Itzhack , Y.: Modulation of cocaine-and methamphetamine-induced behavioural sensitisation by inhibition of bruin nitric oxide synthase. J. Pharmacol. Exp. Ther. 1997, 282, 521-527
11. Jackson, D. M., C. Johansson, L.-M. Lindgren & A. Bengtsson: Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol. Biochem. Behav. 1994, 48, 465-471.
12. Jellett, D. C., E. R. Butelman & J. H. Wood: Nitric oxide synthase inhibitors produce phencyclidine-like behavioural effects in pigeons. Brain Res. 1996, 715, 25-31.
13. Jin J. S. & L. G. D'Alecy: Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor. J. Cardiovasc. Pharmacol. 1996, 28, 439-446.
14. Johansson, C., D. M. Jackson & L. Svensson: Nitric oxide syntase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacol. 1997, 131, 167-173.
15. Johansson, C., D. M. Jackson, J. Zhang & L. Svensson: Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol. Biochem. Behav. 1995, 52, 649-654.
16. Johansson, C., D. M. Jackson & L. Svensson: The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Psychopharmacol. 1994, 116, 437-442.
17. Johansson, C., L. Svensson, O. Magnusson, A. M. Deveney, D. Reif & D. M. Jackson; Nitric oxide synthase, phencyclidine-induced behaviours and schizophrenia: Is the answer NO? In: Interactive monoaminergic basis of brain disorders. Vol. 4. Eds.: T. Palomo, R. J. Beninger & T. Archer, Editorio CYM, Funacion Cerebro y mente. 1999, in press.
18. Karson, C. N., M. D. Mrak, E. Garcis-Rill & W. S. Griffin: Nitric oxide synthase (NOS) in schizophrenia. Abstract 2.15. In: Nitric oxide in the nervous system. Neuropharmacology II. Eds.: J. Garthwaite, S. Snyder & S. Lipton. Oxford, England, 1994a.
19. Karson, C. N., W. S. T. Griffin, R. E. Mrak, M. Husain, T. M. Dawson & S. H. Snyder: Mesopontine nitric oxide synthase concentrations in schizophrenia. Society for Neuroscience Abstract 1994b, 261.10.
20. Kelly , P. A., I. M. Ritchie & G. W. Arbuthnott: Inhibition of neuronal nitric oxide synthase by 7-nitroindazole: effects upon local cerebral blood flow and glucose use in the rat. J. Cerebral Blood Flow & Metabol. 1995, 15, 766-773.
21. Leza, J. C., I. Lizasoain, B. Cuellar & M. A. Moro: Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn-Schmiedebergs Arch. Pharmacol 1996, 353, 349-354.
22. Noda, Y., K. Yamada, H. Furukawa & T. Nabeshima: Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. Eur. J. Pharmacol. 1995, 286, 291-297.
23. Swerdlow, N. R., D. L. Braff, N. Taaid & M. A. Geyer: Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry 1994, 51, 139-154.
24. Swerdlow, N. R., V. Bakshi & M. A. Geyer: Seroquel restores sensorimotor gating in phencyclidine-treated rats. J. Pharmacol. Exp. Therap. 1996, 279, 1290-1299.
25. Waddington, J. L., S. A. Daly, R. P. Downes, A. M. Deveney, P. G. McCauley & K. M. O'Boyle: Behavioural pharmacology of 'D1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D2-like' receptors. Prog. Neuropsychopharmacol. Bio. Psychiat. 1995, 19, 811-831.
26. Wang, Q., D.A. Pelligrino, V. L. ??, H. M. Koening & R. F. Albrecht: The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J. Cerebral Blood Flow & Metabol. 1995, 15, 774-778.
27. Wiley, J. L., K. M. Golden & S. E. Bowen: Effects of modulation of nitric oxide on acoustic startle responding and prepulse inhibition in rats. Eur. J. Pharmacol. 1997, 328, 125-130.
28. Zhang, Z. G., D. Reif, J. Macdonald, W. X. Tang, D. K. Kamp, R. J. Gentile, W. C. Shakespeare, R. J. Murray & M. Chopp: ARL 17477, a potent and selective neuronal nitric oxide synthase inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J. Cerebral Blood Flow & Metabol. 1996, 16, 599-604.
29. Zheng, Y. & R. Laverty: Role of brain nitric oxide in (+/-)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Brain Res. 1998, 795, 257-263.